Axsome Therapeutics
(NASDAQ:AXSM)
$79.185
0.015[0.02%]
Last update: 1:15PM Get Real Time Here
Consensus Rating1
Buy
Highest Price Target1
$190.00
Lowest Price Target1
$49.00
Consensus Price Target1
$110.21

Axsome Therapeutics Stock (NASDAQ:AXSM), Analyst Ratings, Price Targets, Predictions

Axsome Therapeutics Inc has a consensus price target of $110.21, established from looking at the 85 latest analyst ratings. The last 3 analyst ratings were released from Mizuho, Truist Securities, and RBC Capital on March 28, 2024, March 26, 2024, and March 26, 2024. With an average price target of $129 between Mizuho, Truist Securities, and RBC Capital, there's an implied 62.24% upside for Axsome Therapeutics Inc from these 3 analyst ratings.

Analyst Rating Summary1

Analyst Ratings
Nov 23
1
Dec 23
4
Jan
3
Feb
7
Mar
8
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Mizuho
Truist Securities
RBC Capital
Citigroup
HC Wainwright & Co.

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Axsome Therapeutics

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
03/28/2024AXSMBuy Now
Axsome Therapeutics
$79.5137.09%Mizuho
Graig Suvannavejh
$108 → $109MaintainsBuyGet Alert
03/26/2024AXSMBuy Now
Axsome Therapeutics
$79.5188.66%Truist Securities
Joon Lee
→ $150MaintainsBuyGet Alert
03/26/2024AXSMBuy Now
Axsome Therapeutics
$79.5160.99%RBC Capital
Leonid Timashev
$123 → $128MaintainsOutperformGet Alert
03/26/2024AXSMBuy Now
Axsome Therapeutics
$79.5159.73%Citigroup
David Hoang
$125 → $127MaintainsBuyGet Alert
03/26/2024AXSMBuy Now
Axsome Therapeutics
$79.51138.96%HC Wainwright & Co.
Raghuram Selvaraju
$180 → $190MaintainsBuyGet Alert
03/20/2024AXSMBuy Now
Axsome Therapeutics
$79.51126.39%HC Wainwright & Co.
Raghuram Selvaraju
→ $180ReiteratesBuy → BuyGet Alert
03/19/2024AXSMBuy Now
Axsome Therapeutics
$79.5135.83%Baird
Joel Beatty
→ $108Initiates → OutperformGet Alert
03/04/2024AXSMBuy Now
Axsome Therapeutics
$79.51126.39%HC Wainwright & Co.
Raghuram Selvaraju
→ $180ReiteratesBuy → BuyGet Alert
02/27/2024AXSMBuy Now
Axsome Therapeutics
$79.5135.83%Mizuho
Graig Suvannavejh
$112 → $108MaintainsBuyGet Alert
02/21/2024AXSMBuy Now
Axsome Therapeutics
$79.5157.21%Guggenheim
Yatin Suneja
$110 → $125MaintainsBuyGet Alert
02/21/2024AXSMBuy Now
Axsome Therapeutics
$79.5154.7%RBC Capital
Leonid Timashev
$126 → $123MaintainsOutperformGet Alert
02/21/2024AXSMBuy Now
Axsome Therapeutics
$79.5129.54%Cantor Fitzgerald
Charles Duncan
$108 → $103MaintainsOverweightGet Alert
02/20/2024AXSMBuy Now
Axsome Therapeutics
$79.5135.83%Cantor Fitzgerald
Charles Duncan
→ $108ReiteratesOverweight → OverweightGet Alert
02/16/2024AXSMBuy Now
Axsome Therapeutics
$79.5140.86%Mizuho
Graig Suvannavejh
$90 → $112MaintainsBuyGet Alert
02/06/2024AXSMBuy Now
Axsome Therapeutics
$79.5139.61%UBS
Ashwani Verma
→ $111Initiates → BuyGet Alert
01/25/2024AXSMBuy Now
Axsome Therapeutics
$79.5158.47%RBC Capital
Leonid Timashev
→ $126Initiates → OutperformGet Alert
01/22/2024AXSMBuy Now
Axsome Therapeutics
$79.5135.83%Cantor Fitzgerald
Charles Duncan
→ $108ReiteratesOverweight → OverweightGet Alert
01/16/2024AXSMBuy Now
Axsome Therapeutics
$79.5142.12%Piper Sandler
David Amsellem
$90 → $113MaintainsOverweightGet Alert
12/26/2023AXSMBuy Now
Axsome Therapeutics
$79.51126.39%HC Wainwright & Co.
Raghuram Selvaraju
→ $180ReiteratesBuy → BuyGet Alert

FAQ

Q

What is the target price for Axsome Therapeutics (AXSM)?

A

The latest price target for Axsome Therapeutics (NASDAQ: AXSM) was reported by Mizuho on March 28, 2024. The analyst firm set a price target for $109.00 expecting AXSM to rise to within 12 months (a possible 37.65% upside). 43 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Axsome Therapeutics (AXSM)?

A

The latest analyst rating for Axsome Therapeutics (NASDAQ: AXSM) was provided by Mizuho, and Axsome Therapeutics maintained their buy rating.

Q

When was the last upgrade for Axsome Therapeutics (AXSM)?

A

The last upgrade for Axsome Therapeutics Inc happened on August 8, 2023 when B of A Securities raised their price target to $81. B of A Securities previously had an underperform for Axsome Therapeutics Inc.

Q

When was the last downgrade for Axsome Therapeutics (AXSM)?

A

The last downgrade for Axsome Therapeutics Inc happened on August 10, 2021 when Morgan Stanley changed their price target from $105 to $34 for Axsome Therapeutics Inc.

Q

When is the next analyst rating going to be posted or updated for Axsome Therapeutics (AXSM)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Axsome Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Axsome Therapeutics was filed on March 28, 2024 so you should expect the next rating to be made available sometime around March 28, 2025.

Q

Is the Analyst Rating Axsome Therapeutics (AXSM) correct?

A

While ratings are subjective and will change, the latest Axsome Therapeutics (AXSM) rating was a maintained with a price target of $108.00 to $109.00. The current price Axsome Therapeutics (AXSM) is trading at is $79.19, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch